Earnings Verdict
Earnings expected around 4/23, 21 days out. IV remains extremely elevated (72.5% for 4/24), creating a high-probability IV crush opportunity. The regime is firmly 'Pinning' with massive positive GEX (+$143.3M), strongly favoring mean-reversion. Spot has rallied further to $50.38, now 12% above max pain ($45), which may increase gravitational pull lower. The best strategy is a short premium play to harvest inflated IV, with a neutral-to-slightly bearish bias given spot's extended position above max pain.
base 5; +1 for clear IV term structure kink; +1 for high IV and crush potential; -0.5 for mixed flow vs prior bullish; +0 for data quality
Most important: Spot has rallied sharply to $50.38 (12% above max pain), diverging from the pinning regime's mean-reverting force. This increases the probability of a pullback toward the $45-$48 zone.
⚠️Earnings date is inferred from IV term structure kink at 4/24 expiration. Not officially confirmed.
📈Spot has rallied 14.2% to $50.38 since the prior report, now 12% above max pain ($45). This divergence from the pinning regime is a key delta.
🔄Flow regime shifted from 'Bullish' to 'Mixed' (P/C 0.92), with notable put hedging emerging. Gamma regime strengthened to 'Pinning' (GEX +$143M).
Regime Classification
Gamma Regime
Pinning (GEX +$143.3M — mean-reverting)
Flow Regime
Mixed (net prem $60.3M, P/C 0.92)
Spot vs MP
Above max pain by 12.0% (spot $50.38 vs MP $45)
Gamma flip: ~$15.00 — Very low gamma flip at ~$15 due to massive put OI wall. Above $15, dealers are long gamma and will dampen moves, supporting pinning.
Earnings Overview
Next earnings: 2026-04-23 (21 days)inferred_from_iv_kink
Expected moves:
- 4/24 (22d): ±$7.12 (14.1%) [$43.26 - $57.51]
IV Setup
Term structure: Sharp kink at 4/24 expiration (72.5% IV). IV is 61.7% for 4/17 and 71.6% for 5/01, confirming the 4/24 week as earnings-impacted.
Crush estimate: ~8-12 vol pts post-earnings, back to low-mid 60s% range.
Skew: Flow is now mixed (P/C 0.92), with notable put premium flow at $38. Unusual put activity in 4/10 expiration at $49-$50 suggests near-term hedging.
Historical Context
Beat rate: 75% (3/4 quarters)
Avg move vs expected: Insufficient data for reliable move vs. EM comparison.
Directional bias: 3/4 quarters resulted in a positive EPS surprise.
Key Levels
1Max Pain: $45
2Gamma Flip: ~$15
3EM 4/24: $43 - $57.5
4Heavy Call OI: $40, $50, $70
5Heavy Put OI: $15, $20, $30
6Spot: $50
Flow Highlights
Massive bullish premium flow into $60C (+$16.2M net), $50C (+$9.7M net), and $55C (+$9.0M net).
Large, likely institutional, bets on significant upside over the medium term, continuing but less concentrated than prior report.
Notable bearish premium flow into $38P (-$4.8M net) and unusual put volume in 4/10 $50P (7,477 vol vs 181 OI).
Increased hedging or bearish bets against the recent rally, particularly at the $50 strike near spot.
Strategies
Short Strangle (IV Crush & Mean Reversion)
Sell 4/24 $43 Put & Sell 4/24 $57.50 Call
Trigger: Enter 5-7 days before suspected earnings (mid-April).
Capitalizes on extreme IV (72.5%) with a high probability of crush. Strikes are placed just inside the expected move boundaries. The strong pinning regime (GEX +$143M) and spot's 12% premium to max pain increase odds of a contained or mean-reverting move.
Outperforms: Stock stays within the $43-$57.50 range and IV crushes post-earnings. The pinning gamma regime and spot's extended position above max pain favor a pullback, supporting this range.
Underperforms: Stock gaps beyond the short strikes, especially above $57.50 on continued momentum.
Put Ratio Spread (Bearish Mean Reversion)
Buy 1x 4/24 $50 Put / Sell 2x 4/24 $45 Put
Trigger: On any failed rally or reversal near $51.
A defined-risk, credit-biased play for a pullback toward max pain ($45) from the overextended spot price ($50.38). Benefits from elevated IV and the pinning regime's mean-reverting force. The $45 strike aligns with multiple max pain expirations.
Outperforms: Stock declines moderately toward the $45 max pain level but stays above $41. The position profits from theta decay and a pullback from overextended levels.
Underperforms: Stock rallies sharply above $51 or crashes below $41.
Iron Condor (Defined Risk Range)
Sell 4/24 $46 Put, Sell 4/24 $55 Call, Buy 4/24 $43 Put, Buy 4/24 $57.50 Call
Trigger: Enter if spot retraces toward $48-$49 and IV remains elevated 3-5 days before earnings.
A defined-risk version of the strangle, suitable for higher conviction in a contained move. The $46 lower short strike targets a pullback to the upper end of the max pain cluster ($45), while the $55 upper short strike is below the EM high. Collects premium from both sides of elevated IV.
Outperforms: Stock stays within the $46-$55 range post-earnings and IV crushes.
Underperforms: Stock moves beyond the $43-$57.50 wings.
Risk Assessment
!Gap Risk: Expected move is large (±14.1%). A guidance-driven move could easily exceed the strangle/condor wings, especially given the stock's recent momentum.
!IV Crush: A successful short premium trade requires IV to drop significantly. The estimated crush of 8-12 vol points is substantial but not guaranteed if macro vol spikes.
!Spot vs. Regime Mismatch: Spot is 12% above max pain, creating tension with the pinning regime. A violent mean reversion could trigger a larger-than-expected move.
!Liquidity: OI and volume are sufficient for standard strategies. The $0.5 strike increments provide granularity for positioning.
!Sizing: Size short premium positions small due to the large potential move and the spot/regime divergence. The low gamma flip at $15 remains a tail risk warning for extreme downside moves.
What to Watch
?Spot price action relative to the $45 max pain level. A failure to hold above $50 could accelerate a mean reversion.
?IV trajectory on the 4/24 expiration as we approach the suspected 4/23 earnings date.
?Any official confirmation of the Q1 2026 earnings date.
?Unusual put activity at $49-$50 for signs of increased near-term hedging pressure against the rally.